Compositions and methods for inhibition of lineage specific antigens
Abstract:
Disclosed herein are methods of administering an agent targeting a lineage-specific cell-surface antigen and a population of hematopoietic cells that are deficient in the lineage-specific cell-surface antigen for immunotherapy of hematological malignancies.
Information query
Patent Agency Ranking
0/0